Haleon: Too Vanilla For My Liking - I See Why GSK & Pfizer Wanted Out [Seeking Alpha]
Haleon plc American Depositary Shares (Each representing two Ordinary Shares) (HLN)
Company Research
Source: Seeking Alpha
14min Summary GSK spun off Haleon to form a new consumer healthcare entity, driven by activist investor pressure and its underperforming share price. Haleon's financials show steady growth with 2023 revenues at $14.7bn, but concerns remain over debt and reliance on older brands facing competition. Despite initial stock recovery, Haleon's valuation seems high compared to peers like Viatris, and I harbour doubts about its long-term growth and innovation strategy. Given the lack of innovation and over-reliance on existing products, I recommend a "sell" rating for Haleon, questioning its standalone success and justification for current valuation. ac_bnphotos/E+ via Getty Images Investment Overview On 18th July 2022, the Pharma giant GSK ( GSK ) completed the de-merger of its consumer healthcare business to form a new entity, Haleon ( NYSE: HLN ). On Friday, 22nd July, Haleon's American Depositary Shares ("ADS") began trading on the NYSE - each ADS Gain access to all of
Show less
Read more
Impact Snapshot
Event Time:
HLN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HLN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HLN alerts
High impacting Haleon plc American Depositary Shares (Each representing two Ordinary Shares) news events
Weekly update
A roundup of the hottest topics
HLN
News
- Global Antacids Market to Cross ~USD 9 Billion Mark by 2030 | DelveInsight [Yahoo! Finance]Yahoo! Finance
- Haleon Partners with WPP to Launch 'HealthNxt' initiative to Transform Health Conversations in India [Yahoo! Finance]Yahoo! Finance
- Policy Makers At COP29 Urged To Act On ‘Super Pollutant' Gases [Forbes]Forbes
- Flavored Powder Drinks Business Research Report 2024: Global Market to Reach $88 Billion by 2030 - Growing Interest in Immunity-Boosting Beverages Creates New Opportunities [Yahoo! Finance]Yahoo! Finance
- Haleon plc Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions [Yahoo! Finance]Yahoo! Finance
HLN
Sec Filings
- 11/21/24 - Form 6-K
- 11/15/24 - Form 6-K
- 11/14/24 - Form 6-K
- HLN's page on the SEC website